Kim, T.; Ryu, J.; Kong, H.; Park, B.; Kim, K.; Yang, E.; Ahn, T.; Jeon, S.
FOXA1 in Ovarian Cancer: A Potential Therapeutic Target to Enhance Immunotherapy Efficacy. Int. J. Mol. Sci. 2026, 27, 1194.
https://doi.org/10.3390/ijms27031194
AMA Style
Kim T, Ryu J, Kong H, Park B, Kim K, Yang E, Ahn T, Jeon S.
FOXA1 in Ovarian Cancer: A Potential Therapeutic Target to Enhance Immunotherapy Efficacy. International Journal of Molecular Sciences. 2026; 27(3):1194.
https://doi.org/10.3390/ijms27031194
Chicago/Turabian Style
Kim, Taewan, Jaesung Ryu, Hyejeong Kong, Beamjun Park, Kwangseock Kim, Eunjung Yang, Taesung Ahn, and Seob Jeon.
2026. "FOXA1 in Ovarian Cancer: A Potential Therapeutic Target to Enhance Immunotherapy Efficacy" International Journal of Molecular Sciences 27, no. 3: 1194.
https://doi.org/10.3390/ijms27031194
APA Style
Kim, T., Ryu, J., Kong, H., Park, B., Kim, K., Yang, E., Ahn, T., & Jeon, S.
(2026). FOXA1 in Ovarian Cancer: A Potential Therapeutic Target to Enhance Immunotherapy Efficacy. International Journal of Molecular Sciences, 27(3), 1194.
https://doi.org/10.3390/ijms27031194
